InsidersTradesSigma
Track the Prostatype Genomics AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Prostatype Genomics AB has recorded 10 insider filings. Market capitalisation: €15.2m. The latest transaction was disclosed on 18 September 2026 (Purchase). Among the most active insiders: Anders Lundberg. All data is free.
10
Insider Decl.
n/a
Thresholds
€57,328
6 ops.
Buy Volume
€152
1 ops.
Sell Volume
46Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 September 2026
Declarations10 total
380,660 shares@ SEK 0.0610.15% mcap12.9% of flowTeckningsoptionISIN SE0029529783FI:csv-d6a50daa68917d7cdae2
1,287,500 shares0TeckningsoptionISIN SE0029529767FI:csv-c619d63e594e345d7032
1,287,500 shares@ SEK 0.100.84% mcap82.0% of flowInterimsaktieISIN SE0030262895FI:csv-bffeb2b463228f929877
278,936 shares@ SEK 0.05740.11% mcap100.0% of flowOptionISIN SE0029529783FI:csv-9bfe2f0796ba47b6a4f0
500,000 shares@ SEK 0.0560.18% mcap100.0% of flowOptionISIN SE0029529783FI:csv-a4525078569cf2c20a2f
715,000 shares@ SEK 0.100.47% mcap97.7% of flowTeckningsoptionISIN SE0014684569FI:csv-6a8be47796db5500086b
24,248 shares@ SEK 0.070.011% mcap100.0% of flowAktieISIN SE0014684569FI:csv-2968c8e1feb996b5c2d8
1,437,500 shares0TeckningsoptionISIN SE0029529767FI:csv-4d1e1875c74cc399188b
5,750,000 shares@ SEK 0.103.77% mcap100.0% of flowAktieISIN SE0023261532FI:csv-78ed7f85ce46a6e56bfe
2,875,000 shares0TeckningsoptionISIN SE0029529783FI:csv-735015975c41aeefc715
10 of 10 declarations
About Prostatype Genomics AB
Prostatype Genomics AB is a company focused on developing genomic tests for prostate cancer. It is listed on the Stockholm Stock Exchange.